Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHIRISH K KIRTANE

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1982693115
CMS profile
90354
Location
ALTAMONTE SPRINGS, FL

General Payments · PY2018–2024

$5,270.23

  • Reported across 313 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$653.48

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $653.48 37

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $862.80 61
PY2019 $814.62 46
PY2020 $905.45 52
PY2021 $705.66 40
PY2022 $712.63 42
PY2023 $615.59 35
PY2024 $653.48 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $20.00 07/24/2024 Food and Beverage Undisputed 01/23/2026 1078875454 CMS
AstraZeneca Pharmaceuticals LP $19.29 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104353406 CMS
AstraZeneca Pharmaceuticals LP $20.19 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105793330 CMS
AstraZeneca Pharmaceuticals LP $18.37 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104211817 CMS
AstraZeneca Pharmaceuticals LP $15.65 04/24/2024 Food and Beverage Undisputed 01/23/2026 1105527387 CMS
AstraZeneca Pharmaceuticals LP $18.71 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104538102 CMS
AstraZeneca Pharmaceuticals LP $16.52 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105853526 CMS
AstraZeneca Pharmaceuticals LP $22.16 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104304088 CMS
AstraZeneca Pharmaceuticals LP $14.81 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105534782 CMS
AstraZeneca Pharmaceuticals LP $19.70 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104271329 CMS
AstraZeneca Pharmaceuticals LP $19.40 10/23/2024 Food and Beverage Undisputed 01/23/2026 1104594040 CMS
AstraZeneca Pharmaceuticals LP $26.31 11/20/2024 Food and Beverage Undisputed 01/23/2026 1104675813 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.17 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118261837 CMS
GlaxoSmithKline, LLC. $21.78 01/03/2024 Food and Beverage Undisputed 01/23/2026 1115804515 CMS
GlaxoSmithKline, LLC. $1.56 01/03/2024 Food and Beverage Undisputed 01/23/2026 1116408673 CMS
GlaxoSmithKline, LLC. $1.96 01/31/2024 Food and Beverage Undisputed 01/23/2026 1116232019 CMS
GlaxoSmithKline, LLC. $20.04 01/31/2024 Food and Beverage Undisputed 01/23/2026 1116381218 CMS
GlaxoSmithKline, LLC. $5.86 02/07/2024 Food and Beverage Undisputed 01/23/2026 1116546495 CMS
GlaxoSmithKline, LLC. $19.74 03/27/2024 Food and Beverage Undisputed 01/23/2026 1116535130 CMS
GlaxoSmithKline, LLC. $17.77 04/03/2024 Food and Beverage Undisputed 01/23/2026 1116623867 CMS
GlaxoSmithKline, LLC. $20.17 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116451737 CMS
GlaxoSmithKline, LLC. $2.50 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116696123 CMS
GlaxoSmithKline, LLC. $23.78 06/05/2024 Food and Beverage Undisputed 01/23/2026 1116663215 CMS
GlaxoSmithKline, LLC. $20.20 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116583629 CMS
GlaxoSmithKline, LLC. $17.85 09/04/2024 Food and Beverage Undisputed 01/23/2026 1116546445 CMS
GlaxoSmithKline, LLC. $17.30 09/11/2024 Food and Beverage Undisputed 01/23/2026 1116403487 CMS
GlaxoSmithKline, LLC. $5.26 10/02/2024 Food and Beverage Undisputed 01/23/2026 1116243009 CMS
GlaxoSmithKline, LLC. $24.72 10/17/2024 Food and Beverage Undisputed 01/23/2026 1115918340 CMS
GlaxoSmithKline, LLC. $20.56 11/13/2024 Food and Beverage Undisputed 01/23/2026 1115909541 CMS
GlaxoSmithKline, LLC. $17.65 12/18/2024 Food and Beverage Undisputed 01/23/2026 1115775098 CMS
Grifols USA, LLC $17.55 08/07/2024 Food and Beverage Undisputed 01/23/2026 1124726666 CMS
Grifols USA, LLC $17.30 12/11/2024 Food and Beverage Undisputed 01/23/2026 1124726668 CMS
Insmed, Inc. $21.12 08/28/2024 Food and Beverage Undisputed 01/23/2026 1089568157 CMS
Insmed, Inc. $21.18 11/07/2024 Food and Beverage Undisputed 01/23/2026 1089582632 CMS
Insmed, Inc. $22.19 12/05/2024 Food and Beverage Undisputed 01/23/2026 1089565549 CMS
Regeneron Healthcare Solutions, Inc. $14.59 05/01/2024 Food and Beverage Undisputed 01/23/2026 1114088853 CMS
Vifor Pharma, Inc. $19.57 11/27/2024 Food and Beverage Undisputed 01/23/2026 1124059633 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.